Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    HYPEROXALURIA, PRIMARY, TYPE II
Show Display Options
Rank Status Study
1 Completed Endothelial Function in a Sample Group of Patients From the ICARE Study
Condition: Cardiovascular Diseases
Intervention: Drug: Vitamin E 400IU/day
2 Recruiting Rare Kidney Stone Consortium Biobank
Conditions: Primary Hyperoxaluria;   Dent Disease;   APRT Deficiency;   Cystinuria
3 Completed Primary Hyperoxaluria Mutation Genotyping
Condition: Primary Hyperoxaluria
Intervention: Genetic: Genetic Analysis
4 Withdrawn International Registry for Primary Hyperoxaluria
Conditions: Primary Hyperoxaluria;   Nephrocalcinosis;   Kidney Stones
5 Recruiting Primary Hyperoxaluria Mutation Genotyping/Phenotyping
Condition: Primary Hyperoxaluria
Intervention: Other: Genetic Analysis
6 Recruiting Prospective Research Rare Kidney Stones (ProRKS)
Conditions: Hyperoxaluria;   Cystinuria;   Dent Disease;   Lowe Syndrome;   Adenine Phosphoribosyltransferase Deficiency

Indicates status has not been verified in more than two years